Have Researchers Just Found Another Cause of Parkinson’s Disease?

Translate to Spanish or other 102 languages!

New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes
New research suggests another potential biomarker and trigger for Parkinson’s disease. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers from the University of Copenhagen, in Denmark, have made an important breakthrough in our understanding of Parkinson’s disease.
  • Their discovery centres around the damage of mitochondrial DNA in brain cells and its potential as an early biomarker for the disease.
  • As this condition affects over 10 million individuals worldwide, these findings hold significant promise for the future of diagnostics and treatments.
  • With the implications of these damaged DNA pieces likened to an unchecked forest blaze, the research provides hope and a fresh direction in understanding and treating this condition.

Parkinson’s disease is a neurological condition that impacts movement. Initial symptoms involve shaking, diminished sense of smell and difficulties with coordination.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/have-researchers-just-found-another-cause-of-parkinsons-disease

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STC Offers EKG Technician Training to Prepare Students for Careers in Healthcare

South Texas College (STC) is offering an electrocardiography (EKG) technician course through its Continuing Education and Workforce Development division, providing students with hands-on training and an opportunity to take the first step toward a career in healthcare. 

Small Steps in Weight Loss Lead to Big Heart Health Benefits

When people think about weight loss, they often picture dramatic transformations: a major drop on the scale, a new clothing size or a before-and-after photo. But when it comes to overall health, some of the biggest benefits can begin long before those milestone moments.

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer  

The U.S. Food and Drug Administration expanded the approved use of Anktiva (nogapendekin alfa inbakicept-pmln), given with Bacillus Calmette-Guérin (BCG), to include adults with high-grade papillary-only bladder cancer that has not spread into the bladder muscle and has not responded to BCG treatment.

Do You Want to Be an Angel? This Is Your Opportunity

Becoming an angel for someone facing cancer may be as simple as donating $3 or $5. Through DHR Health’s annual Bras for a Cause fundraiser, community members can help patients experiencing financial difficulties while supporting breast cancer awareness and early detection.
- Advertisement -